Related by context. Frequent words. (Click for all words.) 68 RegeneRx Biopharmaceuticals Inc. 68 Celsion Corporation 67 Metabasis Therapeutics Inc. 67 VIA Pharmaceuticals 67 Inc Therapeutic Competitors 67 Nasdaq VRTX 66 Genaera Corporation 66 OncoGenex Pharmaceuticals Inc. 66 BioSpecifics Technologies Corp. 65 Novelos Therapeutics Inc. 65 Inc. NASDAQ CLDA 65 Idera Pharmaceuticals 65 Ore Pharmaceuticals 65 ZIOPHARM Oncology Inc. 65 Nasdaq ISIS 65 Progenics Pharmaceuticals 65 Aradigm Corporation 65 NASDAQ ARIA 64 NASDAQ IMCL 64 IR BioSciences Holdings 64 Pharmion Corporation 64 EPIX Pharmaceuticals Inc. 64 GlaxoSmithKline plc GSK 64 Nasdaq XOMA 64 China Aoxing Pharmaceutical 64 AVANIR Pharmaceuticals 64 Pluristem Therapeutics Inc. 64 Cyclacel Pharmaceuticals Inc. 63 ARIAD Pharmaceuticals Inc. 63 Vicor Technologies Inc. 63 Inc. Nasdaq SGEN 63 Adeona Pharmaceuticals Inc. 63 Chemokine Therapeutics 63 Palatin Technologies Inc. 63 Neurogen Corporation 63 anticancer compound 63 Nymox Pharmaceutical Corporation 63 Repligen Corporation 62 Cortex Pharmaceuticals 62 OTCQX RHHBY 62 NYSE Amex INO 62 Presents Positive 62 Response Genetics Inc. 62 Unigene Laboratories Inc. 62 Achillion Pharmaceuticals Inc. 62 Entest BioMedical Inc. 62 Inc. Nasdaq EXEL 62 ImmunoGen Inc. 62 Rosetta Genomics Ltd. 62 HAYWARD Calif. BUSINESS WIRE 62 Dynavax Technologies Corporation 62 PYMX 62 ImmuneRegen BioSciences Inc. 62 Barrier Therapeutics Inc. 62 Nasdaq DNDN 62 Ligand Pharmaceuticals Incorporated 62 SGMO 62 Immunomedics Inc. 62 Idera Pharmaceuticals Inc. 62 Nasdaq ALTH 62 Panzem R 62 Ironwood Pharmaceuticals Inc. 62 Cardium Therapeutics Inc. 62 Generex Biotechnology Corp. 62 Critical Outcome Technologies 62 Applied NeuroSolutions 62 Hybridon 62 YM BioSciences Inc. 62 Introgen Therapeutics Inc. 61 CRXX 61 MultiCell Technologies Inc. 61 Immunicon Corporation 61 Adherex Technologies Inc. 61 Avanir Pharmaceuticals 61 Biolex Therapeutics 61 AVI BioPharma Inc. 61 Inc. Nasdaq NVAX 61 Healthnostics Inc. 61 Apthera 61 Callisto Pharmaceuticals Inc. 61 AVEO Pharmaceuticals Inc. 61 deforolimus 61 MiddleBrook Pharmaceuticals Inc. 61 Peregrine Pharmaceuticals Inc. 61 Sangamo BioSciences 61 Incyte Corporation 61 IMPAX Laboratories Inc. 61 Ardea Biosciences Inc. 61 Advancing Drugs 61 Neogenix Oncology 61 Ardea Biosciences 61 Celator 61 immunotherapeutics 61 Sangamo BioSciences Inc. 61 PEG SN# 61 Senesco Technologies Inc. 61 GammaCan 61 Gemin X 61 AEterna Zentaris Inc. 61 Inovio Biomedical Corporation 61 DOR BioPharma Inc.